Outcome and clinical characteristics in pleural empyema: A retrospective study

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 6-7, 2011, Pages 430-435

  Nielsen, Jannie ^a   Meyer, Christian N ^a   Rosenlund, Signe ^a  

^a Mental Health Center Glostrup   (Denmark)

Author keywords

empyema; outcome; Pleural infections; treatment

Indexed keywords

ANTIINFECTIVE AGENT; FIBRINOLYTIC AGENT;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HOSPITAL; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PLEURA EMPYEMA; RETROSPECTIVE STUDY; THORAX DRAINAGE; THORAX SURGERY;

AGED; DENMARK; EMPYEMA, PLEURAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 79959244755     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.562527     Document Type: Article

References (28)

1. Smith JA, Mullerworth MH, Westlake GW, Tatoulis J. Empyema thoracis: 14-year experience in a teaching center. Ann Thorac Surg 1991;51:39-42.
2. Lindstrom ST, Kolbe J. Community acquired parapneumonic thoracic empyema: predictors of outcome. Respirology 1999;4:173-9. (Pubitemid 29268717)
3. Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. J Respir Crit Care Med 1999;160:1682-7.
4. Sasse S, Nguyen TK, Mulligan M, Wang NS, Mahutte CK. The effects of early chest tube placement on empyema resolution. Chest 1997;111:1679-83. (Pubitemid 27260102)
5. Ashbaugh DG. Empyema thoracis. Factors influencing morbidity and mortality. Chest 1991;99:1162-5.
6. Huang HC, Chang HY, Chen CW, Lee CH, Hsiue TR. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema. Chest 1999;115:751-6.
7. Davies CW, Gleeson FV, Davies RJ. BTS guidelines for the management of pleural infection. Thorax 2003;58(Suppl 2):ii18-28.
8. Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000;118:1158-71.
9. Davies HE, Davies RJ, Davies CW; BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65(Suppl 2):ii41-53.
10. Frey DJ, Klapa J, Kaiser D. Irrigation drainage and fibrinolysis for treatment of parapneumonial pleural empyema. Pneumologie 1999;53:596-604. (Pubitemid 30076951)
11. Sen S, Senturk E, Pabuscu E, Cokpinar S, Yaman E. [Minimally invasive approach in the pleural fluids]. Tuberk Toraks 2010;58:71-7.
12. Heindorff H, Drenck NE. Pleural empyema. 95 cases treated at a thoracic surgery department. Ugeskr Laeger 1987;149:293-6.
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
14. Meyer CN, Rosenlund S, Nielsen J, Friis-Møller A. Bacteriological aetiology and antimicrobial treatment of pleural empyema. Scand J Infect Dis 2011;43:165-9.
15. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005;352:865-74. (Pubitemid 40300295)
16. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2004;(2):CD002312.
17. Diacon AH, Koegelenberg CF, Bolliger CT. A trial of intrapleural streptokinase. N Engl J Med 2005;352:2243-5.
18. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 1999;159:37-42. (Pubitemid 29036500)
19. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997;52:416-21.
20. Tuncozgur B, Ustunsoy H, Sivrikoz MC, Dikensoy O, Topal M, Sanli M, et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract 2001;55:658-60. (Pubitemid 34023826)
21. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004;170:49-53. (Pubitemid 38997750)
22. Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006;3:75-80.
23. Molnar TF. Current surgical treatment of thoracic empyema in adults. Eur J Cardiothorac Surg 2007;32:422-30. (Pubitemid 47223737)
24. Cassina PC, Hauser M, Hillejan L, Greschuchna D, Stamatis G. Video-assisted thoracoscopy in the treatment of pleural empyema: stage-based management and outcome. J Thorac Cardiovasc Surg 1999;117:234-8. (Pubitemid 29068378)
25. Lim TK, Chin NK. Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis. Eur Respir J 1999;13:514-8. (Pubitemid 29180157)
26. Wozniak CJ, Paull DE, Moezzi JE, Scott RP, Anstadt MP, York VV, et al. Choice of first intervention is related to outcomes in the management of empyema. Ann Thorac Surg 2009;87:1525-30.
27. Wait MA, Sharma S, Hohn J, Dal NA. A randomized trial of empyema therapy. Chest 1997;111:1548-51. (Pubitemid 27260081)
28. Koegelenberg CF, Diaconi AH, Bolligeri CT. Parapneumonic pleural effusion and empyema. Respiration 2008;75:241-50. (Pubitemid 351450393)